Clinical trial · Observational
Genital HPV Infections Before and After Renal Transplantation
The Incidence, Prevalence and Genotype of Genital Human Papillomavirus Infections in Females Before and After Renal Transplantation
NCT01717443CI-TRIAL-00024432completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine the prevalence, incidence and genotype of anogenital HPV infections in women before and after renal transplantation. With this information the investigators can determine the value of vaccination in patients waiting for renal transplantation in the future.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Papillomavirus Infections | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Women, renal disease, transplantation
- description
- Women with end-stage renal disease, whose eligibility for renal transplantation is assessed
Primary outcomes (1)
- measure
- Prevalence of genital HPV infection before and after renal transplantation in women with end stage renal disease
- timeFrame
- 6 months before and 6 months after renal transplantation
- description
- The difference between post-transplantation prevalence (two HPV tests in 6 months after transplantation)and pre-transplantation prevalence (two HPV tests in 6 months before transplantation) will be compared.
Secondary outcomes (2)
- measure
- Incidence of genital HPV infection before and after renal transplantation
- timeFrame
- Assessed every 3 months for 2 years
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female sex; * Age ≥ 18 years at start of the study; * Eligible for renal transplantation; * Operation at the Radboud University Nijmegen Medical Centre; * Signed informed consent; * Mentally capable to understand and comprehend the study and its implications; * Sufficient knowledge of the Dutch language to read, fully understand and complete the Questionnaire. Exclusion Criteria: * Patient not willing to sign and/or return the informed consent form; * Patient refusing additional treatment in case of abnormal findings at the first visit; * Patient being pregnant, or within a period of 3 months after delivery; * Patient being within a period of 3 months after miscarriage.
References
Publications (0)
Data not yet available
No reference posted for this study.